From condemning the Jan. 6 Capitol riots to helping fund the President-elect’s impending inauguration, recent years have seen ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...

2024 was quite a year for significant strategic action among the pharmaceutical giants. Here are five key trends that will ...

An unnamed 19-year-old in Canada's breasts ballooned from a B cup to triple G cup six months after receiving her first dose ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

Scientists discover that SARS-CoV-2 spike protein remains in the brain and skull bone marrow for years post-infection, ...

Novo Nordisk filed another petition with the FDA seeking to block compounding pharmacies from making versions of one of its GLP-1 drugs ...

A patient-led study examines the potential of extended Paxlovid courses for Long COVID relief, documenting varied outcomes ...

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

Alarming DNA Levels Found in Pfizer Vaccines** A shocking revelation has emerged from a peer-reviewed study conducted at an FDA laboratory, revealing signi ...

A new report published in the journal Communications Medicine suggests Pfizer’s (PFE) Paxlovid may help some long Covid patients, but which ...

That’s more than $1.2 billion in unpaid royalties BioNTech is expected to pay for the Pfizer-BioNTech COVID-19 vaccine sales.